The Drug-Induced Cardiotoxicity Website and App

Pacemaker leads - Implantable cardiac devices

Frequency - Incidence

Incidence of cardiac adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for cardiac adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

XIII.a

Pulmonary embolism - Venous thrombosis/thromboembolism

Publications

Nayak R, Fernandes TM, Auger WR, Pretorius GV, Madani MM, Birgersdotter-Green UM

Contribution of Cardiac Implantable Electronic Devices to Thrombus Formation in Patients With Chronic Thromboembolic Pulmonary Hypertension.

JACC. Clinical electrophysiology. 2018;4(11):1431-1436

D'Aloia A, Bonadei I, Vizzardi E, Curnis A

Right giant atrial thrombosis and pulmonary embolism complicating pacemaker leads.

BMJ case reports. 2013;2013

Elbey MA, Kahya Eren N, Kalkan ME, Demirtaş S, Kahraman F, Sayın MR, Oylumlu M, Kayan F

[Cardiac device related infective endocarditis; analysis of 15 cases].

Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir. 2013;41(2):131-5